800
Participants
Start Date
May 31, 2006
Study Completion Date
December 31, 2008
MPC-7869
Oral 800 mg BID
MPC-7869
Oral BID dosing
Phoenix
Tucson
Costa Mesa
San Diego
New Haven
Deerfield Beach
Delray Beach
Gainsville
Hollywood
Miami
Tampa
West Palm Beach
Chicago
Indianapolis
Lexington
Boston
Farmington Hills
St Louis
Rochester
Providence
Charleston
Dallas
Salt Lake City
Aalst
Antwerp
Edegem
Hasselt
Leuven
Sint-Truiden
Calgary
Medicine Hat
Vancouver
Winnipeg
Moncton
Saint John
Halifax
Kingston
London
Ottawa
Peterborough
Toronto
Greenfield Park
Montreal
Verdun
Regina
Odense
Odense C
Bordeaux
Dijon
Marseille
Montpellier
Nice
Reims
Rennes
Saint-Herblain
Toulouse
Tours
Berlin
Bochum
Bonn
Darmstadt
Düsseldorf
Freiburg im Breisgau
Hamburg
Heidelberg
Leipzig
Mannheim
München
Schwerin
Brescia
Milan
Perugia
Pisa
Roma
's-Hertogenbosch
Amsterdam
Blaricum
Barcelona
Bilbao
Getafe. Madrid
Madrid
Lund
Basel
Bath
London
Oxford
Sheffield
Swindon
Belfast
Glasgow
Penarth
Southhampton
Lead Sponsor
Myrexis Inc.
INDUSTRY